Background:
Vertical transmission of
hepatitis B virus (HBV) from infected mothers to their neonates is one of the
most important routes of infection. The exact prevalence rate of HBV in Iranian
pregnant mothers is not well known but based on different studies it is
estimated between 0.35% and 6.5%. The aim of this study was to determine the
seroprevalence of hepatitis B surface antigen (HBsAg) in pregnant women of
selected provinces in Iran.
Methods:
At this cross-sectional
study, seven provinces supposed to be of high and low prevalence of hepatitis B
in the general population selected. Multistage sampling was used to enroll 5261
parturient women who attended the target provinces birth facilities, during
January to March of 2011, were recruited to study. To determine the
statistically significant mean and proportion differences, t-test and χ2 test were used, respectively.
Results:
Overall 1.2% was
positive HBsAg of which 11% of them were hepatitis B e-antigen positive as
well. The eastern and north eastern provinces were considerably higher in HBsAg
seropositivity than the west and northwest of the country.
Conclusions:
In view of the
considerable prevalence of hepatitis B in pregnant women, screening all
pregnant women prioritizing the eastern and north-eastern provinces is strongly
recommended.
Full article at: http://goo.gl/ay3wQu
By: Alireza Shoghli, Seyed Mahmood Nabavi,1 Seyed Moayed Alavian,2 Goodarz Kolifarhood, Mohammad Mehdi Goya,3Roshanak Namazi,4 Mojtaba Fallahnezhad,5 Mansor Mohajeri,6 Nouraldin Mousavinasab, Rahim Sorouri Zanjani,7Mohammad Reza Saeini,8 and Ahmad Jalilvand9
Department of
Social Medicine, Zanjan University of Medical Sciences and Health Services,
Zanjan, Iran
1Department of Tropical and Infectious
Diseases, Shahid Beheshti University of Medical Sciences and Health Services,
Tehran, Iran
2Baqiyatallah Research Center for
Gastroenterology and Liver Diseases, Tehran, Iran
3Director in General, Center for
Communicable Diseases Control, Ministry of Health and Medical Education, Iran
4Department of Hepatitis, Center for
Communicable Diseases Control, Ministry of Health and Medical Education, Iran
5Researcher, Razi Science Researchers
Institute, Iran
6Research Expert, Zanjan University of
Medical Sciences and Health services, Zanjan, Iran
7Department of Microbiology, Zanjan
University of Medical Sciences and Health services, Zanjan, Iran
8Center for Diseases Control, Zanjan
University of Medical Sciences and Health services, Zanjan, Iran
9Department of Pathology, Mousavi Teaching
Hospital, Zanjan University of Medical Sciences and Health services, Zanjan,
Iran
Correspondence to: Dr. Seyed Mahmood Nabavi, Department of
Tropical and Infectious Diseases, Shahid Beheshti University of Medical
Sciences and Health Services, Tehran, Iran. E-mail: moc.oohay@35ivabandoomham
More at: https://twitter.com/hiv_insight
No comments:
Post a Comment